25 06, 2025 Zhasmina Mihaylova et al., Clinically Based Cetuximab Re-Challenge in Patients with RAS Wild-Type Metastatic Colorectal Cancer and Retrospective Analysis of Liquid Biopsies—Preliminary Data. adlitterio663392025-07-04T16:33:09+02:00 Leggi di più
19 06, 2025 Marianna Peroni et al., BRAF fusion as resistance mechanism to osimertinib in EGFR-mutated NSCLC: a case report and review of literature adlitterio663392025-07-04T16:30:51+02:00 Leggi di più
28 05, 2025 Maria Antonietta Castaldi et al., BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient adlitterio663392025-07-04T16:23:13+02:00 Leggi di più
20 05, 2025 Mariavittoria Vescovo et al., Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications adlitterio663392025-07-04T16:19:57+02:00 Leggi di più
7 05, 2025 Laura Antolino et al., TP53 Arg72Pro Polymorphism and Pancreatic Cancer Susceptibility: Assessing rs1042522 as a Risk Factor for Pancreatic Cancer adlitterio663392025-07-04T16:17:47+02:00 Leggi di più
27 01, 2025 Elisabetta Maffei et al., Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers adlitterio663392025-03-07T15:10:22+01:00 Leggi di più
21 12, 2024 Carlotta Ceccon et al., MLH1 gene promoter methylation status partially overlaps with CpG methylator phenotype (CIMP) in colorectal adenocarcinoma adlitterio663392025-01-02T14:47:09+01:00 Leggi di più
29 11, 2024 Ilaria Proietti et al., BRAF-mutant melanoma management: a single center retrospective analysis of patients treated with sequential therapy adlitterio663392025-01-02T14:19:03+01:00 Leggi di più
17 10, 2024 Andrea Boscolo Bragadin et al., Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer adlitterio663392025-01-02T11:24:43+01:00 Leggi di più
30 09, 2024 Silvia Snider et al., Pre-operative mean platelet volume is associated with overall survival in patients with IDH-wildtype glioblastoma undergoing maximal safe resection adlitterio663392025-01-02T11:11:13+01:00 Leggi di più
